Clinical outcome and morbidity in pediatric patients with nasopharyngeal cancer treated with chemoradiotherapy.

about

Clinical outcome and morbidity in pediatric patients with nasopharyngeal cancer treated with chemoradiotherapy.

Item

http://www.wikidata.org/entity/Q38967136

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical outcome and morbidity ...... reated with chemoradiotherapy.

@en

type

Item

label

Clinical outcome and morbidity ...... reated with chemoradiotherapy.

@en

prefLabel

Clinical outcome and morbidity ...... reated with chemoradiotherapy.

@en

P1476

Clinical outcome and morbidity ...... reated with chemoradiotherapy.

@en

P2093

Aanchal Kakkar

http://www.w3.org/2001/XMLSchema#string

Alok Thakar

http://www.w3.org/2001/XMLSchema#string

Ashish Datt Upadhyay

http://www.w3.org/2001/XMLSchema#string

Atul Sharma

http://www.w3.org/2001/XMLSchema#string

Bidhu Kalyan Mohanti

http://www.w3.org/2001/XMLSchema#string

Mehar Chand Sharma

http://www.w3.org/2001/XMLSchema#string

Puja Sahai

http://www.w3.org/2001/XMLSchema#string

Suman Bhasker

http://www.w3.org/2001/XMLSchema#string

P2860

EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.

Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects.

Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma.

Childhood nasopharyngeal carcinoma: from biology to treatment.

Carcinogenesis of nasopharyngeal carcinoma: an alternate hypothetical mechanism.

Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma.

Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.

International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents.

The incidence of Epstein-Barr virus in nasopharyngeal carcinoma of Jordanian patients.

Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.

P304

259-266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.26240

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27681956

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy